A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: Results from the DECLARE-LONG II (Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with long coronary lesions) trial

Journal of the American College of Cardiology

Volumn 57, Issue 11, 2011, Pages 1264-1270

  Lee, Seung Whan ^a   Park, Seong Wook ^a   Kim, Young Hak ^a   Yun, Sung Cheol ^a   Park, Duk Woo ^a   Lee, Cheol Whan ^a   Kang, Soo Jin ^a   Park, Seung Jung ^a   Lee, Jae Hwan ^b   Choi, Si Wan ^b   Seong, In Whan ^b   Lee, Nae Hee ^c   Cho, Yoon Haeng ^c   Shin, Won Yong ^d   Lee, Seung Jin ^d   Lee, Se Whan ^d   Hyon, Min Su ^d   Bang, Duk Won ^d   Choi, Young Jin ^e   Kim, Hyun Sook ^e   Lee, Bong Ki ^f   Lee, Keun ^g   Park, Hoon Ki ^g   Park, Chang Bum ^g   Lee, Sang Gon ^h   Kim, Min Kyu ⁱ   Park, Kyoung Ha ⁱ   Park, Woo Jung ⁱ   more..

^a University of Ulsan College of Medicine   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

^d Soonchunhyang University College of Medicine   (South Korea)

^e Hallym University   (South Korea)

^f Kangwon National University   (South Korea)

^g Seoul Veterans Hospital   (South Korea)

^h Ulsan University College of Medicine   (South Korea)

ⁱ Hankang Sacred Heart Hospital   (South Korea)

Author keywords

cilostazol; coronary artery disease; triple antiplatelet therapy; zotarolimus eluting stent

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; PLACEBO; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PALPITATION; HUMAN; HYPERPLASIA; IMPLANTATION; INTRAVASCULAR ULTRASOUND; LIVER DYSFUNCTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; THROMBOCYTOPENIA; VOLUMETRY;

AGED; ASPIRIN; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TETRAZOLES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 79952435293     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.10.035     Document Type: Article

References (11)

1. E. Tsuchikane, A. Fukuhara, and T. Kobayashi Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty Circulation 100 1999 21 26 (Pubitemid 29297935)
2. J.S. Douglas Jr, D.R. Holmes Jr, and D.J. Kereiakes Coronary stent restenosis in patients treated with cilostazol Circulation 112 2005 2826 2832 (Pubitemid 41641677)
3. S.W. Lee, S.W. Park, and Y.H. Kim Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial) Am J Cardiol 100 2007 1103 1108
4. S.W. Lee, S.W. Park, and Y.H. Kim Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus: the DECLARE-DIABETES trial J Am Coll Cardiol 51 2008 1181 1187
5. S.D. Wiviott, E.M. Antman, and C.M. Gibson Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J 152 2006 627 635 (Pubitemid 44396884)
6. W.K. Laskey, C.W. Yancy, and W.H. Maisel Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 78, 2006 Circulation 115 2007 2352 2357 (Pubitemid 46685904)
7. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878 (Pubitemid 29511140)
8. J. Fajadet, W. Wijns, and G.J. Laarman Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
9. S.W. Lee, S.W. Park, and S.C. Yun Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry) Am Heart J 159 2010 284 291
10. Y. Han, Y. Li, and S. Wang Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes Am Heart J 157 2009 733 739
11. K.Y. Chen, S.W. Rha, and Y.J. Li Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Circulation 119 2009 3207 3214